54527-74-1

2-Butenoic acid, 3-amino-, 2-(dimethylamino)ethyl ester

Order [ 54527-74-1 ] Now

Benzo[b][1,7]naphthyridin-1(2H)-one,7-chloro-5,10-dihydro-5-[[(1-methylethyl)amino]methyl]-5-(trifluoromethyl)-

Propanamide, 2,2-dimethyl-N-[8-(1,3,3-trimethylbutoxy)-2-quinolinyl]-

Benzenesulfonamide,4-fluoro-N-[3-[[5-[(4-methyl-3-pyridinyl)carbonyl]-2-thiazolyl]amino]propyl]-

Piperazine,1-[5-[(4-fluorophenyl)ethynyl]-2-pyridinyl]-4-[[5-(2-pyrimidinyl)-1-pentenyl]sulfonyl]-

2-Propen-1-one, 3-(2-chloro-5,8-dimethoxy-3-quinolinyl)-1-phenyl-

1-Cyclohexadecene-1-methanol, 2-methyl-, (E)-

1,4-Phenanthrenedione, 2,5,7-trimethoxy-

Carbamic acid, [(3,5-dichlorophenyl)methyl]-,[1-[(4-chlorophenyl)sulfonyl]-1,2,3,4-tetrahydro-2-quinolinyl]methyl ester

[1,1'-Biphenyl]-2-carboxamide,N-(4-methoxyphenyl)-2'-[[(1-oxo-3-phenylpropyl)amino]methyl]-

Benzo[g]quinoxaline, 2,3-bis[[4-(4-fluorophenyl)-1-piperazinyl]methyl]-,hydrochloride

2H-1,4-Benzothiazine-6-carboxylic acid,4-[(3-fluorophenyl)methyl]-3,4-dihydro-3-oxo-, methyl ester

Piperazine,1-[5-(2,4-difluorophenyl)-2-pyrimidinyl]-4-[[2-(formylhydroxyamino)-4-(2-pyrimidinyl)butyl]sulfonyl]-

5-METHYL-6-PHENYLISOCYTOSINE

4H-Pyrazol-4-one, 3,5-diamino-,[3-fluoro-4-(4-morpholinylmethyl)phenyl]hydrazone

2-Butenamide, 2-acetyl-3-[(4-methoxyphenyl)amino]-N-phenyl-

[1,1'-Biphenyl]-2-carboxamide,2'-(aminomethyl)-N-[(2,4-difluorophenyl)methyl]-

Carbamic acid,[[2'-[[[2-(4-pyridinyl)ethyl]amino]carbonyl][1,1'-biphenyl]-2-yl]methyl]-,1,1-dimethylethyl ester

Piperazine, 1-(5-iodo-2-pyridinyl)-4-(methylsulfonyl)-

Piperazine,1-[2,3'-bipyridin]-6'-yl-4-[[2-(hydroxyamino)-5-(2-pyrimidinyl)pentyl]sulfonyl]-

Carbamic acid,[[2'-[[(2-pyridinylmethyl)amino]carbonyl][1,1'-biphenyl]-2-yl]methyl]-,4-methoxyphenyl ester

2-Propenoic acid, 2-bromo-3-(4-fluorophenyl)-, ethyl ester, (2Z)-

Benzo[b]thiophene-6-carbonitrile, 3-cyclopentyl-

Benzamide,2-[(benzoyloxy)methyl]-N-[8-(1,3,3-trimethylbutoxy)-2-quinolinyl]-

2-Propen-1-one,3-(2-chloro-7-methyl-3-quinolinyl)-1-(2,4-dichlorophenyl)-

1H-Inden-1-one, 2-(bromomethyl)-2-(3-butenyl)-2,3-dihydro-

Piperazine,1-[[2-(hydroxyamino)-5-(2-pyrimidinyl)pentyl]sulfonyl]-4-[5-(2-thienylethynyl)-2-pyridinyl]-

4H-Cyclopenta[b]thiophene, 2-methyl-3,5-diphenyl-

Butanedioic acid, (2-nitropropyl)-, dimethyl ester

2,4-Pteridinediamine, 6,7-Bis[(4-Butylphenyl)Methyl]-

Piperazine,1-[5-(3,4-difluorophenyl)-2-pyridinyl]-4-[[2-(formylhydroxyamino)-5-(2-pyrimidinyl)pentyl]sulfonyl]-

Piperazine,1-[[2-(formylhydroxyamino)-5-(2-pyrimidinyl)pentyl]sulfonyl]-4-[4-(3-furanyl)phenyl]-

4H-Naphth[2,3-e]-1,3-oxazin-4-one,3-(5-chloro-2,4-dimethoxyphenyl)-2,3-dihydro-2-imino-

Piperazine,1-[[2-(formylhydroxyamino)-5-(2-pyrimidinyl)pentyl]sulfonyl]-4-[5-(2-furanyl)-2-pyrimidinyl]-

Butanedioic acid, (2-nitroheptyl)-, dimethyl ester

Clobetasol Propionate (TEVA API)

Azane;(2-methoxyphenyl)carbamodithioic Acid

54527-74-1 msds

CAS No 54527-74-1 supplier

CASNo 54527-74-1 distributor

CAS # 54527-74-1 manufacturer

CAS Number 54527-74-1 safety

CAS RN 54527-74-1 wholesale

2026-10-12 Find 2-Butenoic acid, 3-amino-, 2-(dimethylamino)ethyl ester,CAS No.54527-74-1,Formula:C8H16N2O2 in NewOrgChem